NCT06365918 2025-02-17
Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis
M.D. Anderson Cancer Center
Phase 1 Withdrawn
M.D. Anderson Cancer Center
Stanford University
Genentech, Inc.
Eurofarma Laboratorios S.A.